Cargando…
Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease
Background: Aromatic aldehydes, with their ability to increase the oxygen affinity of sickle hemoglobin, have become important therapeutic agents for sickle cell disease (SCD). One such compound, voxelotor, was recently approved for SCD treatment. Methyl 6-((2-formyl-3-hydroxyphenoxy)methyl) picolin...
Autores principales: | Ahmed, Tarek A., El-Say, Khalid M., Abd-Allah, Fathy I., Omar, Abdelsattar M., El-Araby, Moustafa E., Muhammad, Yosra A., Pagare, Piyusha P., Zhang, Yan, Mohmmad, Khadijah A., Abdulmalik, Osheiza, Safo, Martin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401948/ https://www.ncbi.nlm.nih.gov/pubmed/34452107 http://dx.doi.org/10.3390/pharmaceutics13081148 |
Ejemplares similares
-
Design, Synthesis, and Antisickling Investigation of a Thiazolidine Prodrug of TD-7 That Prolongs the Duration of Action of Antisickling Aromatic Aldehyde
por: Alhashimi, Rana T., et al.
Publicado: (2023) -
VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions
por: Abdulmalik, Osheiza, et al.
Publicado: (2020) -
An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling
por: Omar, Abdelsattar M., et al.
Publicado: (2020) -
Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents
por: Omar, A. M., et al.
Publicado: (2019) -
Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease
por: Alhashimi, Rana T., et al.
Publicado: (2022)